MediGene Company

MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.


Industry: Dendritic Cells, Atrificial Vectors and Immune Cells
Headquarters: Martinsried, Bayern, Germany
Founded Date: 1994-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 1
Total Funding: 29379427
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-02-02
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership